TP53, a tumor suppressing gene which acts as a transcriptional activator, and bestradiol (estradiol), a ligand for the estrogen receptor, were identified as upstream regulators across both regions (Fig. 3C, G, I). This evidence concerns the gene ESR1 and neoplasm.